Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Rhea-AI Summary

Invivyd (NASDAQ: IVVD) has announced its participation in the H.C. Wainwright 3rd Annual BioConnect Investor Conference. The company's management will engage in a fireside chat on Tuesday, May 20, 2025, at 11:00 a.m. ET in New York. Management will also be available for investor meetings during the conference.

Interested investors attending the conference can arrange meetings through their H.C. Wainwright representative. The fireside chat will be accessible via live webcast on the company's investor relations website at investors.invivyd.com and will remain available for approximately 30 days after the presentation.

News Market Reaction

+2.76%

1 alert

+2.76% News Effect

On the day this news was published, IVVD gained 2.76%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the H.C. Wainwright 3^rd Annual BioConnect Investor Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in New York, NY.

In addition to the fireside chat, the management team will host investor meetings at the conference. Investors participating in the conference who are interested in meeting with Invivyd management should contact their H.C. Wainwright representative.

A live webcast of the fireside chat will be available in the investor section of the company's website at investors.invivyd.com and will be archived for approximately 30 days following the presentation.

About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. 

Contacts:

Media Relations
(781) 208-1747
media@invivyd.com

Investor Relations
(781) 208-1747
investors@invivyd.com

FAQ

When is Invivyd (IVVD) presenting at the H.C. Wainwright BioConnect Conference 2025?

Invivyd will participate in a fireside chat at the H.C. Wainwright BioConnect Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in New York.

How can investors access Invivyd's presentation at the H.C. Wainwright Conference?

Investors can watch the fireside chat via live webcast on Invivyd's investor relations website at investors.invivyd.com. The presentation will be archived for approximately 30 days.

How can investors schedule meetings with Invivyd management at the H.C. Wainwright Conference?

Investors participating in the conference who wish to meet with Invivyd management should contact their H.C. Wainwright representative to arrange meetings.

How long will Invivyd's H.C. Wainwright Conference presentation be available for replay?

The webcast of Invivyd's fireside chat will be archived and available for approximately 30 days following the presentation on the company's investor website.